Christina Dishmond, NP
Nurse Practitioner · Cornelius, NCNPI 1487262762
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.6% of the total across 211 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 18.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,076, more than ten times the $32 reported in 2021. Among nurse practitioner clinicians in NC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 211 payments — averaging $19.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$772
- GSK$662
- Regeneron Healthcare Solutions, Inc.$397
- Novartis$303
- AbbVie$294
- CSL Behring$263
- plus $1K from 22 others
What the payments were for
- Food & beverage$4,02198%
- Education$992%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 27 | $772 |
| GSK | 50 | $662 |
| Regeneron Healthcare Solutions, Inc. | 14 | $397 |
| Novartis | 18 | $303 |
| AbbVie | 15 | $294 |
| CSL Behring | 10 | $263 |
| Incyte Corporation | 15 | $235 |
| Sanofi | 11 | $211 |
| ARS Pharmaceuticals Operations, Inc. | 11 | $158 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $133 |
| Grifols USA, LLC | 4 | $99 |
| Pharming Healthcare, Inc. | 4 | $76 |
| Biocryst US Sales Co., LLC | 3 | $70 |
| Hikma Pharmaceuticals USA | 3 | $59 |
| Genentech USA, Inc. | 3 | $56 |
| Pfizer | 2 | $43 |
| Amgen | 2 | $43 |
| Optinose US, Inc. | 2 | $38 |
| Novo Nordisk | 2 | $32 |
| Alk-abello, Inc | 1 | $24 |
| Greer Laboratories, Inc. | 1 | $22 |
| Organon | 1 | $21 |
| LEO Pharma Inc. | 1 | $21 |
| Azurity Pharmaceuticals, Inc. | 1 | $21 |
| Blueprint Medicines Corporation | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $15 |
| Biocryst Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,120 in reported general payments places this provider in the 90th percentile of 4,393 nurse practitioner providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 17 | $370 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Cornelius
- Sandrivette JohnsonRaleigh$573K
- Ayeshia WrightMocksville$145K
- Jeanann VawterGastonia$97K
- Terra KampJacksonville$72K
- Mary DilorenzoCharlotte$71K
- Olivia OgburnWinston Salem$70K
- Bridget ArchambaultDurham$57K
- Deborah MayerChapel Hill$55K
- Amber SeilerGreensboro$55K
- Stephanie PascaleRaleigh$54K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.